NDC 73377-094 - Losartan Potassium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 73377-094
- Package NDCs from labels
- 73377-094-01, 73377-094-02, 73377-094-03, 73377-094-04, 73377-094-05, 73377-094-06, 73377-094-07
- Manufacturer
- AX Pharmaceutical Corp
- Effective date
- 2026-05-19
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Losartan Potassium - AX Pharmaceutical Corp | AX Pharmaceutical Corp | 2026-05-19 | BULK INGREDIENT - ANIMAL DRUG |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 73377-094-01 | Losartan Potassium | 100 g in 1 JAR | POWDER | 100 | 7 | |
| 73377-094-02 | Losartan Potassium | 25 g in 1 JAR | POWDER | 25 | 7 | |
| 73377-094-03 | Losartan Potassium | 1000 g in 1 JAR | POWDER | 1000 | 7 | |
| 73377-094-04 | Losartan Potassium | 97 g in 1 JAR | POWDER | 97 | 7 | |
| 73377-094-05 | Losartan Potassium | 80 g in 1 JAR | POWDER | 80 | 7 | |
| 73377-094-06 | Losartan Potassium | 500 g in 1 JAR | POWDER | 500 | 7 | |
| 73377-094-07 | Losartan Potassium | 1500 g in 1 JAR | POWDER | 1500 | 7 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Losartan Potassium | LOSARTAN POTASSIUM | Proficient Rx LP | 4b298291-4251-4af8-a436-58a3443a7978 | 2024-08-01 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| LOSARTAN POTASSIUM 100 mg | LOSARTAN POTASSIUM | NuCare Pharmaceuticals,Inc. | a955160f-3c2d-3366-e053-2a95a90a65ea | 2024-07-17 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | NuCare Pharmaceuticals,Inc. | aa58c629-f7d9-a6e0-e053-2995a90ac188 | 2024-07-17 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | NuCare Pharmaceuticals,iNc. | 54b363c4-00bb-08db-e054-00144ff8d46c | 2024-07-17 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | af44b2b0-1204-43c9-8ec1-d081d35b8f2b | 2024-06-28 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | NuCare Pharmaceuticals,Inc. | 9c0809dc-cbdd-1a33-e053-2995a90a4825 | 2024-06-20 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | NuCare Pharmaceuticals,Inc. | 9f1c20aa-2028-412d-e053-2995a90a1368 | 2024-06-20 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | NuCare Pharmaceuticals,Inc. | a11075f1-f7d0-0c3d-e053-2995a90a0c9d | 2024-06-20 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | NuCare Pharmaceuticals,Inc. | a1123700-f4c7-2b62-e053-2a95a90a87d6 | 2024-06-20 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | NuCare Pharmaceuticals,Inc. | 9130921b-02f0-82d6-e053-2995a90a9c0a | 2024-06-19 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | NuCare Pharmaceuticals,Inc. | 91305ca4-7d56-2052-e053-2995a90a5d61 | 2024-06-19 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | NuCare Pharmaceuticals,Inc. | 97a50b38-f5b3-0a96-e053-2995a90a345f | 2024-06-19 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | NuCare Pharmaceuticals,Inc. | 8c2b3412-254b-8fa9-e053-2a95a90a7dc6 | 2024-06-18 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | NuCare Pharmaceuticals,Inc. | 6eec2a4c-6b5c-11a5-e053-2991aa0aa56b | 2024-06-10 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | NuCare Pharmaceuticals,Inc. | 72c97b7f-d945-5106-e053-2a91aa0a9b3b | 2024-06-10 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 1bb08103-04ee-47a6-a9ad-290e169feb51 | 2024-05-06 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | c8740506-c679-4c41-a96a-8ddbcddd72c6 | 2024-05-06 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Proficient Rx LP | c6ed6f74-0eca-4f99-8c7e-dd3f56167f01 | 2024-05-01 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 6bd15e74-2ca2-49c8-8c01-0a647d3fa5df | 2024-01-18 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | a4aa7f77-c98d-4b70-84bb-e16a06fc7952 | 2023-12-04 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.